182 Cryptochrome/photolyase FAD-binding domain-related
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Nucleosides, nucleotides, and analogues | 28 | 8.7 | 3.21× | q < 0.0001 | |
| Homogeneous non-metal compounds | 6 | 6.8 | 0.88× | q = 0.88 | |
| Homogeneous metal compounds | 13 | 15.5 | 0.84× | q = 0.56 | |
| Organic oxygen compounds | 2 | 6.3 | 0.32× | q = 0.11 | |
| Organoheterocyclic compounds | 15 | 4.9 | 3.09× | not tested | |
| Benzenoids | 1 | 2.3 | 0.43× | not tested | |
| Lipids and lipid-like molecules | 1 | 3.5 | 0.28× | not tested | |
| Organic acids and derivatives | 1 | 4.9 | 0.20× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03147 | FAD | Flavin adenine dinucleotide | 186 |
| DB12676 | MHF | Modufolin | 13 |
| DB04447 | DTT | 1,4-Dithiothreitol | 10 |
| DB00131 | AMP | Adenosine phosphate | 8 |
| DB02596 | APC | alpha,beta-Methyleneadenosine 5'-triphosphate | 2 |
| DB02618 | NDS | Ethyl Dimethyl Ammonio Propane Sulfonate | 2 |
| DB02210 | HEZ | Hexane-1,6-Diol | 1 |
| DB03247 | FMN | Flavin mononucleotide | 1 |
| DB03462 | TDR | Thymine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| FAD | FLAVIN-ADENINE DINUCLEOTIDE | 214 |
| SF4 | IRON/SULFUR CLUSTER | 63 |
| CL | CHLORIDE ION | 32 |
| FDA | DIHYDROFLAVINE-ADENINE DINUCLEOTIDE | 24 |
| MGmetal | MAGNESIUM ION | 20 |
| MHF | 5,10-METHENYL-6,7,8-TRIHYDROFOLIC ACID | 13 |
| DTT | 2,3-DIHYDROXY-1,4-DITHIOBUTANE | 10 |
| DLZ | 1-deoxy-1-(6,7-dimethyl-2,4-dioxo-3,4-dihydropteridin-8(2H)-yl)-D-ribitol | 9 |
| AMP | ADENOSINE MONOPHOSPHATE | 8 |
| HDF | 8-HYDROXY-10-(D-RIBO-2,3,4,5-TETRAHYDROXYPENTYL)-5-DEAZAISOALLOXAZINE | 8 |
| DYX | 1-(4-chlorophenyl)-N-[2-(4-methoxyphenyl)-5,5-bis(oxidanylidene)-4,6-dihydrothieno[3,4-c]pyrazol-3-yl]cyclopentane-1-carboxamide | 5 |
| FO1 | 1-deoxy-1-(8-hydroxy-2,4-dioxo-3,4-dihydropyrimido[4,5-b]quinolin-10(2H)-yl)-D-ribitol | 5 |
| 2CX | N-[(2S)-3-(9H-carbazol-9-yl)-2-hydroxypropyl]-N-(furan-2-ylmethyl)methanesulfonamide | 4 |
| ZNmetal | ZINC ION | 4 |
| GDmetal | GADOLINIUM ATOM | 3 |
| H8X | N-[(2R)-3-carbazol-9-yl-2-oxidanyl-propyl]-N-(furan-2-ylmethyl)methanesulfonamide | 3 |
| MNmetal | MANGANESE (II) ION | 3 |
| NAmetal | SODIUM ION | 3 |
| 5YH | 1-[(2R)-3-[3,6-bis(fluoranyl)carbazol-9-yl]-2-oxidanyl-propyl]imidazolidin-2-one | 2 |
| APC | DIPHOSPHOMETHYLPHOSPHONIC ACID ADENOSYL ESTER | 2 |